Dr. Jörg Hölzing is Co-Founder and Co-CEO of QNOMX AG, a Swiss precision oncology startup making genomic insights actionable for cancer care. With over 20 years of experience in healthcare and executive roles at Roche Diagnostics , he brings deep expertise in digital health, diagnostics, and strategic partnerships and is passionate about advancing healthcare through innovation and collaboration.